🇺🇸 FDA
Patent

US 11992523

Method for producing chikungunya virus (CHIKV) virus-like particles comprising the C, E2, and E1 structural proteins

granted A61KA61K2039/5258A61K2039/55566

Quick answer

US patent 11992523 (Method for producing chikungunya virus (CHIKV) virus-like particles comprising the C, E2, and E1 structural proteins) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue May 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K2039/5258, A61K2039/55566, A61K39/12, A61P